Researchers are investigating the potential of low-dose lithium, a trace element found in drinking water, to protect against dementia and improve memory, according to recent findings. While not widely recommended by doctors, studies suggest a link between slightly elevated lithium levels in water supplies and lower rates of cognitive decline.
Although the human brain has a fixed number of cells at birth, it retains the capacity to form new connections, known as synapses, throughout life. The research focuses on how lithium, in minute quantities, might support this synaptic plasticity and defend against neurodegenerative processes.
One ongoing clinical trial at Johns Hopkins University in the United States is evaluating the safety and tolerability of low-dose lithium orotate in adults diagnosed with early-stage Alzheimer's disease. This trial aims to gather more data on the efficacy of lithium supplementation for individuals experiencing cognitive impairment.
Dr. Thomas MacLaren, a consultant psychiatrist at the Chelsea and Westminster Hospital in London, has noted that several studies have observed a correlation between increased lithium concentrations in tap water and reduced instances of dementia. This observational evidence has spurred further scientific inquiry into the neuroprotective properties of lithium.
The exploration into lithium's role in brain health extends beyond observational studies, with clinical trials actively seeking to confirm its potential therapeutic benefits for conditions like Alzheimer's. The findings could inform future public health strategies and medical recommendations regarding cognitive well-being.